XML 58 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock Option Plans (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of restricted stock units A summary of the Company’s RSUs as of December 31, 2021 is presented in the table below:
Number of RSUsWeighted-Average Fair
Value
Balance at December 31, 2020— $— 
Granted11,130,711 8.67 
Vested(2,742,608)10.39 
Forfeited(1,146,123)7.61 
Balance at December 31, 20217,241,980 $8.19 
Schedule of estimate the value of options granted The following table provides a range of the assumptions for shares granted in 2021:
2021
Expected volatility
65% - 70%
Expected term (years)
0.60 - 1.90
Expected dividend yieldn/a
Risk-free interest rate
.3% - .6%
The following assumptions were used to estimate the value of options granted during the years ended December 31, 2021 and December 31, 2020:
Year ended December 31,
2021
Forfeiture rate26.2  %
Volatility62.00  %
Expected term (years)5.33
Risk-free interest rate0.53  %
Expected dividends— 
Year ended December 31,
2020
Forfeiture rate
19.62% - 25.76%
Volatility
47.00% - 62.00%
Expected term (years)
4.95 - 7.00
Risk-free interest rate
0.26% - 1.73%
Expected dividends— 
Schedule of activity of stock option plan The following table summarizes the activity of the Company’s stock option plan:
Stock
Number of
Options		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term
(Years)		Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 20205,931,024 $2.61 8.10$70,192 
Options granted
4,231 14.45 
Options exercised
(1,103,263)2.21 
Options cancelled or expired and returned to plan
(2,457,488)2.38 

Outstanding as of December 31, 20212,374,504 3.00 8.25$375 
Vested and exercisable to vest as of December 31, 2021767,785 2.97 7.91$352 
Vested and expected as of December 31, 20211,670,909 $3.00 8.11$374 
Schedule of stock-based compensation expense for employee and nonemployee options The following table illustrates stock-based compensation expense for employee and non-employee RSUs and options for the year ended December 31, 2021 and 2020 (in thousands).
Years Ended December 31,
20212020
Cost of revenues
$883 $104 
Research and development
3,932 714 
Sales and marketing
1,222 44 
Other operating expenses
27,865 595 
Total stock-based compensation
$33,902 $1,457